Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
American Journal of Medical Genetics|January 25, 2002
Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old ageBastiaan T Heijmans, P Eline Slagboom, Jacobijn Gussekloo, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutationsKirsten L White, James M Chen, Nicolas A Margot, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 2, 2007
Low-level K65R mutation in HIV-1 reverse transcriptase of treatment-experienced patients exposed to abacavir or didanosineEvguenia S Svarovskaia, Nicolas A Margot, Andrew S Bae, et al.
Biochemical and Biophysical Research Communications|December 14, 1990
Mutagenic properties of a unique abasic site in mammalian cellsA Gentil, G Renault, C Madzak, et al.
AIDS (London, England)|December 16, 2010
Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapyDerrick D Goodman, Yun Zhou, Nicolas A Margot, et al.
Metabolism: Clinical and Experimental|October 23, 2008
Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitusMichael Stolinski, Saima Alam, Nicola C Jackson, et al.
The Proceedings of the Nutrition Society|June 5, 2020
Report of a member-led meeting: how stable isotope techniques can enhance human nutrition researchBarbara A Fielding, Bruce A Griffin, Wendy Hall, et al.
Antiviral Research|December 27, 2011
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4Nicolas A Margot, Rebecca M Hluhanich, Gregg S Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2018
Lixisenatide Reduces Chylomicron Triacylglycerol by Increased ClearanceMartin B Whyte, Fariba Shojaee-Moradie, Sharaf E Sharaf, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2010
Treatment with recombinant human insulin-like growth factor (rhIGF)-I/rhIGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistanceFiona M Regan, Rachel M Williams, Anna McDonald, et al.
Pageof 15